Cubist Systematic Strategies’s Valion Bio VBIO Stock Holding History

Cubist Systematic Strategies’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17	Closed	-$3.03K	–	3907
2023 Q2	$3.03K	Buy	+17	New	+$3.64K	﹤0.01%	3339

Other funds holding VBIO

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cubist Systematic Strategies's VBIO Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Valion Bio (VBIO) in Q3 2023, closing a stake of 17 shares — an estimated $3.03K sold.

Cubist Systematic Strategies first reported a position in VBIO in Q2 2023 and held it in 1 quarter. The position peaked at $3.03K in Q2 2023. 6 funds tracked by Wall St. Rank hold VBIO as of Q3 2023.

Cubist Systematic Strategies reported no remaining Valion Bio position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 17 Valion Bio shares in Q3 2023, an estimated $3.03K.
Cubist Systematic Strategies first reported a position in Valion Bio in Q2 2023 and held it in 1 quarter.
Cubist Systematic Strategies's Valion Bio position peaked at $3.03K in Q2 2023.
6 funds tracked by Wall St. Rank held Valion Bio as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.